Management of severe facial pain using nerve block technique.
- Conditions
- Other disorders of facial nerve,
- Registration Number
- CTRI/2019/01/017154
- Lead Sponsor
- PGIMER Chandigarh
- Brief Summary
Trigeminal neuralgia (TGN) is characterized by the sudden onset of recurrent severe pain in trigeminal nerve distribution.The condition is severely disabling with impaired quality of life. Idiopathic TGN is difficult to treat by medications and interventional therapy may be required in 25-30% of patients. Trigeminal nerve block is usually performed for the relief of severe refractory pain of TGN by using landmark technique or under fluoroscopy guidance. The ultrasound-guided trigeminal nerve block via pterygopalatine fossa has been demonstrated in few case reports and found to be effective in patients with refractory trigeminal neuralgia and atypical facial pain. Therefore, the present study has been planned to evaluate the feasibility and effectiveness of ultrasound-guided trigeminal nerve block via pterygopalatine fossa for the management of idiopathic trigeminal neuralgia. In this study, 40 consecutive patients of refractory trigeminal neuralgia will receive trigeminal nerve block with 4 mL of bupivacaine 0.25% and 40 mg triamcinolone in the pterygopalatine fossa using ultrasound guidance. The patients will be followed up for 3 months to assess global pain relief and reduction in analgesic medications. Any adverse effect, patients’ satisfaction, and the number of patients having effective pain relief for 3 months will be recorded.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 40
40 consecutive adult patients of idiopathic trigeminal neuralgia resistant to pharmacological treatment will be included.
Allergy to local anesthetics or steroids, infection, coagulopathy, and pregnancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patients will be asked to rate their 24-hour global pain experience including severity, duration, frequency of the episodes, and to report it as a percentage of global pain relief at 2 weeks, 1 month, 2 month and 3 months after procedure
- Secondary Outcome Measures
Name Time Method Duration of procedure, complications and success rate during and after the procedure and at 1, 2 and 3 months
Trial Locations
- Locations (1)
Post Graduate Institute of Medical Education and Research
🇮🇳Chandigarh, CHANDIGARH, India
Post Graduate Institute of Medical Education and Research🇮🇳Chandigarh, CHANDIGARH, IndiaDr Neerja BhartiPrincipal investigator9915575145bhartineerja@yahoo.com